Evidence map›Paper›PMID 22941559›Full record

ReviewCurrent allergy and asthma reports2013

Immune response to nanomaterials: implications for medicine and literature review.

Saad Syed, Adeel Zubair, Marianne Frieri

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current allergy and asthma reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Biocompatibility of nanomaterials and their immunological properties.Biomedical materials (Bristol, England) · 2021
    Review
  5. Review
  6. Review
  7. Article
  8. Biomimetic synthesis of AgNPs fromIET nanobiotechnology · 2017
    Article
  9. Modern trends in animal venom research - omics and nanomaterials.World journal of biological chemistry · 2017
    Article
  10. Rapid synthesis of silver nanoparticles byIET nanobiotechnology · 2016
    Article
  11. Review
  12. Review
  13. Article
  14. Gold nanoparticles to improve HIV drug delivery.Future medicinal chemistry · 2015
    Article
  15. Review: Immunology of sinusitis, trauma, asthma, and sepsis.Allergy & rhinology (Providence, R.I.) · 2015
    Article
  16. Etiology and pathogenesis of late-onset Alzheimer's disease.Current allergy and asthma reports · 2014
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Saad SyedDivision of Allergy Immunology, Department of Medicine and NSLIJ Health Care Systems, Nassau University Medical Center, 2201Hempstead Turnpike, East Meadow, NY 11554, USA.
Adeel Zubair
Marianne Frieri
Modern Meadow (United States) · USNassau University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanomaterials, substances below 100 nm, are increasingly used in medical diagnosis and treatment every day. The use of such materials has helped deliver drugs across the blood-brain barrier, alleviate allergy symptoms, specifically target cancer or HIV cells, and more. However, the tunable characteristics of such materials have not been perfected. The different materials, sizes, shapes, and structures have different responses on the body. This paper will investigate the successful treatments made with nanoparticles and some general health effects. A review of the literature revealed an inflammatory response and an increased production of reactive oxidative species (ROS) to be common immune responses to nanomaterial use. The mechanisms by which the inflammatory response and ROS production occur will also be discussed.

Indexed as

AnimalsAntibody FormationBiological TransportBlood-Brain BarrierHumansInflammationNanomedicineNanoparticlesReactive Oxygen SpeciesReactive Oxygen Species

Identifiers

PMID22941559
OpenAlexW2079076050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.